<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190126042496N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-01-19</date_registration>
      <primary_sponsor>Neurofunctional Research Center of Shohada Tajrish Hospital</primary_sponsor>
      <public_title>pedicle screw fixation with cement augmentation versus without in the treatment of spinal stenosis following posterior spinal fusion surgery, superiority according to bone mineral density: A three-arm randomized open clinical trial.</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the efficacy of pedicle screw fixation with cement augmentation versus without in the treatment of spinal stenosis following posterior spinal fusion surgery, superiority according to bone mineral density: A three-arm randomized open clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-01-18</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>92</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68082</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Informed consent will be obtained from each participant before patient enrolment in the study. Patients who meet all the inclusion criteria and none of the exclusion criteria will be consecutively included and stratified into two groups according to T-score: Group I= non-osteoporotic (T-score &gt;-1.5) and Group II= osteoporotic (T-score ≤-1.5). Afterward, the osteoporotic group will be randomized into one of the following study arms by the  statistician according to a random allocation sequence by a random number table: Group II-A = osteoporosis without cement augmentation or Group II-B =osteoporosis+ cement augmentation. The intervention will be communicated to the patient by a surgeon.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Patients with spinal canal stenosis are candidates for posterior spinal fusion surgery. Condition 2: Osteoporosis is defined as a mean adjusted T-score of -1.5 or below.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: (Group II-A) A group of osteoporotic patients with T-score ≤ -1.5 and spinal canal stenosis who will undergo pedicle screw fixation without cement augmentation. Intervention 2: Intervention group: (Group II-B) A group of osteoporotic patients with T-score ≤ -1.5 and spinal canal stenosis who will undergo pedicle screw fixation with cement augmentation (0.8-1 cc of polymethylmethacrylate (PMMA) per screw, bilaterally into each vertebra with a viscosity slightly thinner than toothpaste. The screw is implanted into the vertebra prior to the complete solidification of the cement, and the rod is attached following solidification.). Intervention 3: Control group: A group of non-osteoporotic patients with T-score &gt; -1.5 and spinal canal stenosis who will undergo pedicle screw fixation without cement augmentation.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammadreza Shahmohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Next to Taleghani hospital, Shahid Araabi St., Yaman St., Shahid Chamran highway, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985717443</zip>
        <telephone>+98 21 23871</telephone>
        <email>mr_shahmohammadi@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammadreza Shahmohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Next to Taleghani hospital, Shahid Araabi St., Yaman St.,Shahid Chamran highway, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985717443</zip>
        <telephone>+98 21 23871</telephone>
        <email>mr_shahmohammadi@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>diagnosed with spinal stenosis by symptoms, signs, and imaging examinations
advised for PSF surgery through pedicle screw fixation
older than 40 years old</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>diagnosed with other vertebral disorders such as tumors or infections
serious medical problems such as congestive heart failure and cirrhosis, calcium absorption disorder, hyperparathyroid disease
diagnosed with spinal deformities including sagittal plane deformity and coronal imbalance</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M48.0</hc_code>
      <hc_code>M81</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Spinal stenosis</hc_keyword>
      <hc_keyword>Osteoporosis without current pathological fracture</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: (Group II-A) A group of osteoporotic patients with T-score ≤ -1.5 and spinal canal stenosis who will undergo pedicle screw fixation without cement augmentation.</i_keyword>
      <i_keyword>Intervention group: (Group II-B) A group of osteoporotic patients with T-score ≤ -1.5 and spinal canal stenosis who will undergo pedicle screw fixation with cement augmentation (0.8-1 cc of polymethylmethacrylate (PMMA) per screw, bilaterally into each vertebra with a viscosity slightly thinner than toothpaste. The screw is implanted into the vertebra prior to the complete solidification of the cement, and the rod is attached following solidification.)</i_keyword>
      <i_keyword>Control group: A group of non-osteoporotic patients with T-score &gt; -1.5 and spinal canal stenosis who will undergo pedicle screw fixation without cement augmentation.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Changes in VAS score before and after posterior spinal fusion surgery. Timepoint: The VAS score will be measured before and after one year of surgery to determine the degree of pain reduction. Method of measurement: The patient's pain level is assessed on a horizontal line of 100 mm that its left end represents no pain, and the right end corresponds to the most severe pain that can be experienced. The patient is asked to mark the pain intensity they are experiencing currently.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Proximal junctional kyphosis (PJK): A rise of over 20° in the Cobbs' angle between the lower endplate of the upper instrumented vertebra (UIV) and the upper endplates of two super-adjacent vertebrae between the immediate postoperative and after one year follow-up. Timepoint: Immediately after surgery and after one year follow-up. Method of measurement: Through upright lateral radiographs.</sec_outcome>
      <sec_outcome>Proximal junctional vertebral fracture (PJVF): The fracture of UIV or UIV +1. Timepoint: Immediately after surgery and after one year follow-up. Method of measurement: Anteroposterior and lateral plain radiographs, and computed tomography (CT).</sec_outcome>
      <sec_outcome>Adjacent segment disease (ASD):Degeneration of the mobile spinal segments above or below a fused spinal segment. Timepoint: Immediately after surgery and after one year follow-up. Method of measurement: Anteroposterior and lateral plain radiographs, and computed tomography (CT).</sec_outcome>
      <sec_outcome>Screw fracture: Fracture of rod following pedicle screw fixation surgery. Timepoint: Immediately after surgery and after one year follow-up. Method of measurement: Anteroposterior and lateral plain radiographs, and computed tomography (CT).</sec_outcome>
      <sec_outcome>Rod fracture: Fracture of rod following pedicle screw fixation surgery. Timepoint: Immediately after surgery and after one year follow-up. Method of measurement: Anteroposterior and lateral plain radiographs, and computed tomography (CT).</sec_outcome>
      <sec_outcome>Screw loosening: The appearance of a radiolucent rim &gt;1 mm (a halo) around at least one screw on radiography or CT scan. Timepoint: Immediately after surgery and after one year follow-up. Method of measurement: Anteroposterior and lateral plain radiographs, and computed tomography (CT).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Neurofunctional Research Center of Shohada Tajrish Hospital</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-05-10</approval_date>
        <contact_name>Institutional Research Ethics Committee - Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>3rth floor, Faculty of Medicine, next to Taleghani Hospital, Evin, Shahid Chamran Highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
